Physician

Garvin Kent Chastain, MD

According to 2025 Medicare claims, Garvin Chastain, MD (NPI: 1518933829) practices internal medicine in the Cleveland, TN market, with the plurality of this provider's patient population coming from Bradley, TN. This provider's primary affiliated billing organization is CLEVELAND MEDICAL ASSOCIATES, PLLC (NPI: 1093723330; TIN: 20-2603391) and primary practice location at 37312-4369. Chastain is affiliated with the Aledade 154 FL GA MSSP Enhanced (ACO ID: A5357), participating under the MSSP model.

Chastain's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 470 traditional Medicare patients, billed 1,841 HCPCS/CPT codes, and received $97,564 in Medicare payments. The top billing code was G0439 (Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit). Part D data shows 11,768 prescription claims across 722 beneficiaries totaling $1,193,128 in drug costs, led by Ozempic (Semaglutide). DME data shows 429 claims. Open Payments data shows 73 records totaling $1,313. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a higher plateau to a lower plateau, from $334,815 to $97,564. Concurrently, Part D prescription costs have changed little. For DME billing, reported payments moved up and down with repeated peaks and valleys, starting at $89,013 and ending at $49,924.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	946	9,430	$334,815
2016	1,072	8,493	$211,622
2017	1,448	12,263	$260,438
2018	1,314	10,987	$266,317
2019	1,234	8,899	$233,607
2020	1,078	7,067	$176,720
2021	745	3,507	$149,253
2022	528	2,714	$139,255
2023	457	2,098	$117,315
2024	470	1,841	$97,564

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	825	16,469	$902,743
2016	897	18,198	$973,010
2017	1,160	18,643	$1,082,638
2018	1,146	17,303	$1,151,773
2019	1,080	16,066	$1,125,164
2020	934	15,035	$1,251,202
2021	907	13,584	$1,102,764
2022	790	13,030	$1,180,141
2023	714	12,479	$1,397,691
2024	722	11,768	$1,193,128

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	124	588	$43,783
2016	106	516	$16,907
2017	90	507	$14,477
2018	180	587	$19,113
2019	108	444	$13,478
2020	131	429	$17,096
2021	159	514	$35,706
2022	90	518	$56,095
2023	86	587	$52,750
2024	107	429	$29,686

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
G0439	Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit	162	162	$121
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	282	571	$73
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	59	90	$43
G0446	Annual, face-to-face intensive behavioral therapy for cardiovascular disease, individual, 15 minutes	163	163	$24
G0444	Annual depression screening, 5 to 15 minutes	161	161	$17

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Ozempic	Semaglutide	203	7,264	$212,003
Eliquis	Apixaban	191	8,065	$151,048
Jardiance	Empagliflozin	84	5,370	$99,409
Mounjaro	Tirzepatide	48	1,434	$48,764
Trulicity	Dulaglutide	25	1,374	$46,969

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4239	Supply allowance for non-adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service	N	N/R	54	$14,839
A6196	Alginate or other fiber gelling dressing, wound cover, sterile, pad size 16 sq. in. or less, each dressing	N	15	18	$2,510
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	N/R	24	$1,634
A7030	Full face mask used with positive airway pressure device, each	N	N/R	20	$1,631
A7033	Pillow for use on nasal cannula type interface, replacement only, pair	N	N/R	17	$1,583

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	73	$1,313	Novo Nordisk Inc
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Garvin Kent Chastain, MD?

Tedicare shows public-source Medicare data for Garvin Kent Chastain, MD (NPI 1518933829), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Garvin Kent Chastain, MD have ACO affiliation data?

Garvin Kent Chastain, MD is shown with ACO affiliation data for Aledade 154 FL GA MSSP Enhanced (MSSP, ACO ID A5357).

What billing organization is linked to Garvin Kent Chastain, MD?

Garvin Kent Chastain, MD is linked to CLEVELAND MEDICAL ASSOCIATES, PLLC (billing NPI 1093723330) in the available physician profile data.

Does Garvin Kent Chastain, MD have Open Payments data?

Garvin Kent Chastain, MD has 73 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.